Yesterday Immobel issued a trading update that gives comfort in the FY26 bond repayment of EUR 125.0m which was the biggest short term risk of the investment case. This triggered us to increase our TP from EUR 23.0 to EUR 28.0 with a BUY recommendation (prev. accumulate). The reasoning is explained in this new company note. We still don't think the dividend will come back in the next 2 years as the focus remains deleveraging. However, the share price reflected a dilutive capital raise which has ...
Yesterday, Alfen announced that CEO Marco Roeleveld will retire by year-end for medical reasons. Marco Roeleveld has been a key figure since 1997 and led Alfen’s IPO in 2018. The board has begun the search for his successor. This announcement comes after CCO Michelle Lesh stepped down in March 2025
Alfen announced last evening that its CEO, Marco Roeleveld, will retire by the end of the year due to health reasons. Roeleveld, who led Alfen through its 2018 IPO and significant growth, emphasized that the decision, though difficult, is necessary to focus on his recovery. The Supervisory Board has initiated the search for a successor and expressed confidence in a smooth leadership transition. Alfen enters a transition phase where the appointment of a new CEO and the definition of a refreshed s...
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar mo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.